ANTH | Anthera Pharmaceuticals, Inc. Annual & Quarterly

Annual Cash Flows

(In USD)

Breakdown	2022	2021	2020	2019	2017	2016
Operating Cash Flow	-	-	-	-	-36.9 Million	-48.91 Million
Net Income	-	-	-	-	-26.87 Million	-55.52 Million
Depreciation & Amortization	-	-	-	-	281 Thousand	266 Thousand
Deferred income taxes	-	-	-	-	-	-
Stock-based compensation	-	-	-	-	4.37 Million	6.73 Million
Change in working capital	-	-	-	-	-5.04 Million	1.34 Million
Other non-cash items	-	-	-	-	-9.64 Million	-1.74 Million
Investing Cash Flow	-	-	-	-	-	-766 Thousand
Investments in PPE	-	-	-	-	-	-766 Thousand
Acquisitions	-	-	-	-	-	-
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	18.25 Million	23.57 Million
Debt repayment	-	-	-	-	-	-
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	-	-	-	-	18.25 Million	6.73 Million
Other Financing Activities	-	-	-	-	18.25 Thousand	16.84 Million
Accounts receivables	-	-	-	-	-	326 Thousand
Accounts payables	-	-	-	-	-2.95 Million	-477 Thousand
Inventory	-	-	-	-	-	1.63 Million
Other working capital	-	-	-	-	-2.09 Million	-138 Thousand
Cash at beginning of period	-	-	-	-	20.84 Million	46.95 Million
Cash at end of period	-	-	-	-	2.19 Million	20.84 Million
Capital Expenditure	-	-	-	-	-	-766 Thousand
Effect of forex changes on cash	-	-	-	-	-	-
Net cash flow / Change in cash	-	-	-	-	-18.64 Million	-26.1 Million
Free Cash Flow	-	-	-	-	-36.9 Million	-49.68 Million

Breakdown	2022 FY	2021 FY	2020 FY	2019 FY	2018 Q1	2017 FY
Operating Cash Flow	-	-	-	-	-	-
Net Income	-	-	-	-	-7.72 Million	-26.87 Million
Depreciation & Amortization	-	-	-	-	161 Thousand	281 Thousand
Deferred income taxes	-	-	-	-	-	-
Stock-based compensation	-	-	-	-	3.3 Million	4.37 Million
Change in working capital	-	-	-	-	-1.83 Million	-5.04 Million
Other non-cash items	-	-	-	-	-3.29 Million	-9.64 Million
Investing Cash Flow	-	-	-	-	358 Thousand	-
Investments in PPE	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	358.00	-
Financing Cash Flow	-	-	-	-	14.91 Million	18.25 Million
Debt repayment	-	-	-	-	-	-
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	-	-	-	-	12.38 Million	18.25 Million
Other Financing Activities	-	-	-	-	2.53 Million	18.25 Thousand
Accounts receivables	-	-	-	-	-	-
Accounts payables	-	-	-	-	-97 Thousand	-2.95 Million
Inventory	-	-	-	-	-	-
Other working capital	-	-	-	-	-1.73 Million	-2.09 Million
Cash at beginning of period	-	-	-	-	2.19 Million	20.84 Million
Cash at end of period	-	-	-	-	8.08 Million	2.19 Million
Capital Expenditure	-	-	-	-	-	-
Effect of forex changes on cash	-	-	-	-	-	-
Net cash flow / Change in cash	-	-	-	-	5.89 Million	-18.64 Million
Free Cash Flow	-	-	-	-	-9.38 Million	-36.9 Million